Linked e-resources

Details

Intro; Preface; Acknowledgment; Contents; 1: Mechanisms of Metastasis; Normal Tissue Versus Malignant Neoplasia; Molecular and Genetic Features; Genomic Instability; Metabolic Alterations; Limitless Replicative Potential; Angiogenesis, Vasculogenesis, Vascular Co-option, Lymphangiogenesis, and Neoneurogenesis; Autophagy; Apoptosis, Necroptosis, and Anoikis; Apoptosis; Anoikis; Necroptosis; Proteases: Degradation of the Extratumoral Spaces; Epithelial-Mesenchymal Transition; EMT Regulation; Mesenchymal-Epithelial Transition; EMT, Stem Cells, and Tumor-Initiating Cells; Cell Adhesion.

Tumor-Stroma InteractionsEscape from Immune Surveillance; Metastasis; Tumor Migration; Circulating Tumor Cells; Metastasis Suppressor Genes; Exosomes in Cancer Metastasis; Invasion of the Vessels; Extravasation; Metastatic Colonization, Tumor Dormancy, and Reactivation; Last Words; References; 2: Tumor Deposits; Mechanisms, Morphology, and Differential Diagnosis; Morphology and Differential Diagnosis of Free Tumor Deposits; Clinical Relevance of Free Tumor Deposits; Mechanisms of Tumor Deposit Formation.

Neurotrophic Extravascular Migratory Metastasis, Perineural Invasion, and Perineural-Type Tumor Deposit FormationAngiotrophic Extravascular Migratory Metastasis and Perivascular-Type Tumor Deposit Formation; Tumor Deposits Associated with Lymphatics; Other Routes of Tumor Spread; References; 3: Tumor Deposits in Colorectal Cancer; Prognostic Factors in Colorectal Carcinomas; Proposed Mechanisms and Morphology of TDs in Colorectal Carcinomas; Classifications of TDs in Colorectal Carcinomas; Prognostic Studies on Tumor Deposits in Colorectal Carcinomas.

Discussion About TDs in Colorectal CarcinomasNeoadjuvant Radiotherapy and Tumor Deposits; References; 4: Tumor Deposits in Gastric Cancer; Morphologic and Molecular Classifications of the Gastric Carcinomas and Prognostic Features; EBV-Associated DNA Hypermethylation; Microsatellite Instability; Genomically Stable Tumors; Chromosomally Unstable Tumors; Prognostic Factors in Gastric Carcinomas; HER2: A Predictive Biomarker in Gastric Carcinoma; Trastuzumab for Gastric Cancer (ToGA Trial) (Bang YJ 2010); Methods for Evaluation of HER2 Amplification; Immunohistochemistry.

In Situ HybridizationThe Diagnostic Combination of IHC and ISH for HER2 Amplification; The Incidence of HER2 Amplification in Gastric and Gastroesophageal Carcinoma Cases; Implications for Treatment; Proposed Mechanisms and Morphology of Tumor Deposits in Gastric Carcinomas; Classifications of Tumor Deposits in Gastric Carcinomas; Prognostic Studies on Tumor Deposits in Gastric Carcinomas; Discussion About TDs in Gastric Carcinomas; References; 5: Tumor Deposits in Esophageal Carcinomas; Morphologic and Molecular Classifications of the Esophageal Carcinomas.

Browse Subjects

Show more subjects...

Statistics

from
to
Export